Clinical Trial Update: 68Ga-AAZTA-NI-093 PET/CT: First-in-human Study [EARLY_Phase 1]

View source ↗

Summary

First-in-human PET/CT study of the radiopharmaceutical 68Ga-AAZTA-NI-093 for prostate cancer, currently in EARLY_PHASE1 and enrolling at the First Affiliated Ho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 68Ga-AAZTA-NI-093

Snippet

Sponsor: First Affiliated Hospital of Fujian Medical University | Conditions: Prostate Cancer (Adenocarcinoma) | EARLY_Phase 1 | Status: RECRUITING